背景:临床就诊是风湿性疾病护理的基本方面,但是指南中基本上没有关于适当访问频率的建议,几乎没有研究,和不一致的报道。本系统综述的目的是总结有关主要风湿性疾病就诊频率的证据。
方法:本系统综述是根据PRISMA指南进行的。标题/摘要筛选,全文筛选,并由两名独立作者进行提取。提取或计算年度就诊频率,并按疾病类型和研究国家进行分层。计算加权平均年访问频率。
结果:筛选了273条相关的手稿记录,和28在应用选择标准后被纳入.纳入的研究在美国和非美国之间平均分配,并在1985年至2021年之间发表。大多数(n=16)集中在类风湿性关节炎(RA),系统性红斑狼疮(SLE,n=5),和纤维肌痛(FM,n=4)。对于RA,美国风湿病学家的平均年就诊频率为5.25,4.80美国非风湿病学家,3.29非美国风湿病学家,非美国非风湿病学家为2.74。对于SLE,非风湿病学家的年度访视频率远高于美国风湿病学家(12.3vs3.24).对于FM,美国风湿病学家的年访视频率为1.80,非美国风湿病学家的年访视频率为0.40.从1982年到2019年,风湿病学家的就诊频率呈下降趋势。
结论:在全球范围内,风湿病临床就诊的证据有限且异质性。然而,总体趋势表明,近年来美国的访问频率更高,而访问频率更低。
Clinical visits are a fundamental aspect of rheumatic disease care, but recommendations for appropriate visit frequencies are largely absent from guidelines, scarcely studied, and inconsistently reported. The aim of this systematic
review was to summarize the evidence pertaining to visit frequencies for major rheumatic diseases.
This systematic
review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Title/abstract screening, full-text screening, and extraction were carried out by 2 independent authors. Annual visit frequencies were either extracted or calculated and stratified by disease type and country of study. Weighted mean annual visit frequencies were calculated.
A total of 273 relevant manuscript records were screened, and 28 were included after applying selection criteria. The included studies were equally divided between US and non-US and were published between 1985 and 2021. Most (n = 16) focused on rheumatoid arthritis (RA), systemic lupus erythematosus (SLE; n = 5), and fibromyalgia (FM; n = 4). For RA, the average annual visit frequencies were 5.25 for US rheumatologists, 4.80 for US non-rheumatologists, 3.29 for non-US
rheumatologists, and 2.74 for non-US non-
rheumatologists. For SLE, annual visit frequencies for non-
rheumatologists were much higher than for US
rheumatologists (12.3 versus 3.24). For FM, annual visit frequencies were 1.80 for US
rheumatologists and 0.40 for non-US
rheumatologists. There was a decreasing trend of visit frequency to rheumatologists from 1982 to 2019.
Evidence for rheumatology clinical visits was limited and heterogeneous on a global scale. However, general trends suggest more frequent visits in the US and less frequent visits in recent years.